Topics

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The acquisition expands ORBIS’ manufacturing capacity and technical expertise in reusable plastic pallets, lids, and trays, enabling faster design, prototyping, and production for pharma and broader supply chain applications.

ORBIS Acquires Robinson Industries to Boost Reusable Packaging and Thermoforming Capabilities

The deal strengthens Körber’s SAP supply chain and digital manufacturing consulting portfolio, extends its global footprint, and creates Körber Stellium to deliver end-to-end supply chain and software solutions.

Körber Purchases Majority Stake in Stellium to Grow Global SAP Supply Chain Consulting Services

Podcasts

In today’s Pharma Pulse, a new national survey exposes the depth of America’s prescription access crisis, while AstraZeneca and Eli Lilly commit billions of dollars to next-generation weight-loss therapies and domestic manufacturing.

Pharma Pulse: The Access Gap

In today’s Pharma Pulse, HHS issues guidance for manufacturer-direct drug discounts, while clinical data warns of significant weight regain after stopping tirzepatide and semaglutide.

Pharma Pulse: HHS Bypasses PBMs and the Reality of GLP-1 Weight Regain

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, naming 15 new negotiation targets and signaling continued efforts to rein in prescription drug spending.

CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs

In today’s Pharma Pulse, the AAP defies federal vaccine cuts, Morris & Dickson scales its specialty footprint, and Insilico Medicine targets cardiometabolic health with a new partnership.

Pharma Pulse: AI’s $120M Cardiometabolic Play

The acquisition strengthens M&D’s specialty portfolio, broadens access to plasma-derived therapies, and supports phased integration focused on regulatory compliance.

Morris & Dickson Acquires Prodigy Health to Expand Specialty and Plasma Distribution Capabilities

In today’s Pharma Pulse, extreme weather tests the resilience of community pharmacies, while CMS proposes a near-flat 0.09% update for Medicare Advantage and Part D payments in 2027.

Pharma Pulse: Climate Risks to the Supply Chain 

How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike.

Why Direct-to-Patient Is the Pharma Industry’s Next Power Move

In today’s Pharma Pulse, Congress races to secure funding, while Novavax nets a half-billion-dollar validation of its non-aluminum vaccine technology.

Business and Finance